Health Catalyst, Inc.
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
HCAT$1.44-4.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations for the and (unaudited)
Condensed Consolidated Statements of Operations
(in thousands, except per share data)
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Revenue(1): | ||||
| Technology | $40,686 | $52,051 | $138,949 | $156,409 |
| Professional services | 15,597 | 24,272 | 58,577 | 80,048 |
| Total revenue | 56,283 | 76,323 | 197,526 | 236,457 |
| Cost of revenue, excluding depreciation and amortization: | ||||
| Technology | 16,166 | 17,203 | 51,637 | 53,120 |
| Professional services | 16,076 | 21,304 | 51,525 | 71,045 |
| Total cost of revenue, excluding depreciation and amortization | 32,242 | 38,507 | 103,162 | 124,165 |
| Operating expenses: | ||||
| Sales and marketing | 8,563 | 14,361 | 29,508 | 42,305 |
| Research and development | 9,503 | 12,281 | 30,308 | 39,859 |
| General and administrative | 11,999 | 16,069 | 37,887 | 38,515 |
| Depreciation and amortization | 9,728 | 12,614 | 32,822 | 37,618 |
| Goodwill impairment | — | — | 122,548 | 28,769 |
| Total operating expenses | 39,793 | 55,325 | 253,073 | 187,066 |
| Gain on sale of business | 65,889 | — | 65,889 | — |
| Income (loss) from operations | 50,137 | (17,509) | (92,820) | (74,774) |
| Loss on extinguishment of debt | (9,494) | — | (9,494) | — |
| Interest and other expense, net | (540) | (4,679) | (8,417) | (11,838) |
| Income (loss) before income taxes | 40,103 | (22,188) | (110,731) | (86,612) |
| Income tax benefit (provision) | 393 | (41) | (336) | (337) |
| Net income (loss) attributable to common stockholders | $40,496 | $(22,229) | $(111,067) | $(86,949) |
| Net income (loss) per share, basic | $0.54 | $(0.32) | $(1.50) | $(1.25) |
| Net income (loss) per share, diluted | $0.53 | $(0.32) | $(1.50) | $(1.25) |
| Weighted-average shares outstanding used in calculating net income (loss) per share, basic | 75,386 | 70,377 | 73,990 | 69,525 |
| Weighted-average shares outstanding used in calculating net income (loss) per share, diluted | 75,932 | 70,377 | 73,990 | 69,525 |
(1)Includes amounts attributable to related party transactions. See Note 18 for further details.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.